Louise Downs

Publications

• A systematic review of Hepatitis B virus (HBV) prevalence and genotypes in Kenya: Data to inform clinical care and health policy
• A systematic review of Hepatitis B virus (HBV) prevalence and genotypes in Kenya: Data to inform clinical care and health policy
• Data from an electronic health informatics pipeline to describe clearance dynamics of Hepatitis B surface antigen (HBsAg) and e-Antigen (HBeAg) in chronic HBV infection
• Case Report: Application of hepatitis B virus (HBV) deep sequencing to distinguish between acute and chronic infection
• A systematic review and meta-analysis of the risk of hepatitis B virus (HBV) genotypic resistance in people treated with entecavir or tenofovir
• Where do those data go? Reuse of screening results from clinical trials to estimate population prevalence of HBV infection in adults in Kilifi, Kenya
• Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort.
• Hepatitis C Virus (HCV) diagnosis, epidemiology and access to treatment in a UK cohort
• Electronic Health Informatics Data To Describe Clearance Dynamics of Hepatitis B Surface Antigen (HBsAg) and e Antigen (HBeAg) in Chronic Hepatitis B Virus Infection
• Liver function tests and fibrosis scores in a rural population in Africa: estimation of the burden of disease and associated risk factors
• Bimodal distribution and set point HBV DNA viral loads in chronic infection: retrospective analysis of cohorts from the UK and South Africa
• Bimodal distribution and set point HBV DNA viral loads in chronic infection: retrospective analysis of cohorts from the UK and South Africa [version 2; peer review: 2 approved]
• Bimodal distribution and set point HBV DNA viral loads in chronic infection: retrospective analysis of cohorts from the UK and South Africa
• SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus [version 2; peer review: 2 approved]
• Case Report: Application of hepatitis B virus (HBV) deep sequencing to distinguish between acute and chronic infection [version 1; peer review: 2 approved]
• STRIKE-HBV: establishing an HBV screening programme in Kilifi, Kenya—challenges, successes and lessons learnt
• Peer support for people living with hepatitis B virus—A foundation for treatment expansion
• Hepatitis B Core Related Antigen - Does it meet our expectations? Evidence from Cohorts in the United Kingdom and South Africa
• Establishing laboratory reference ranges for adults and children in Kilifi, Kenya
• Evaluation of Hepatitis B core related antigen (HBcrAg) as a biomarker in cohorts from the United Kingdom and South Africa
• Hepatitis B core related antigen (HBcrAg) point of care tests as a risk stratification tool: experience from Kenya
• Hepatitis B core-related antigen (HBcrAg) point-of-care tests as a risk stratification tool: experience from Kenya
• Investigating understanding, experience and barriers to care for people living with chronic hepatitis B virus infection in Kilifi, Kenya.
• Investigating understanding, experience and barriers to care for people living with chronic hepatitis B virus infection in Kilifi, Kenya
• Hepatitis B core-related antigen (HBcrAg) point-of-care tests as a risk stratification tool for treatment eligibility: experience from Kenya
• "I think it would be better for those of us who have the disease not to be ashamed." Insights from people living with chronic hepatitis B virus infection and healthcare workers providing HBV care in Kilifi, Kenya.
• “I think it would be better for those of us who have the disease not to be ashamed”. Insights from people living with chronic hepatitis B virus infection and healthcare workers providing HBV care in Kilifi, Kenya
• Hepatitis B Core-Related Antigen Point-of-Care Tests as a Risk Stratification Tool for Treatment Eligibility: Experience From Kenya